testosterone cypionate,arv-471,zanubrutinib,selumetinib
beigene,spdr s&p biotech,pfizer,mirati,onconova therapuetics,arvinas,legend biotech,ishares biotechnology,merck,immunic therapeutics,astrazeneca
['koselugo', 'brukinsa', 'derm', 'arv-471', 'depo', 'zanubrutinib', 'molecular,partners', 'legend bio', 'immunic', ' arvinas ', 'pfizer', 'beigene', '$imux', 'onconova', 'mirati', '$ibb', '$xbi']
biotech stock news 5/8 @ close $xbi $85 (-0.5%)
$ibb $130.9 (-0.8%) $trvn 394% approval of olinvyk in china
$rxrx 9% to acquire cyclica &amp; valence
$imux 8% data presented '23
$gkos 8% nda accepted; pdufa set
$inmb 4% ind cleared
$kdny 4% upcoming presentation '23 
Catalyst Calendar, Big Mover stocks to watch, & model portfolios. Database & tools to help with your biotech stock research. not investment advice. https://t.co/5njnanqtbK